Mitomycin C Therapy
Mitomycin C Therapy is a pharmacological intervention involving the topical application of mitomycin C, a chemotherapeutic agent, to selectively inhibit abnormal epithelial cell proliferation in the management of ocular surface neoplasia.
3.5K
Publications
160.3K
Citations
13.9K
Authors
2.7K
Institutions
Publications per year
2017–2026
324
Parents
3.5K
R.D. James, Rob Glynne‐Jones, Helen Meadows et al. · The Lancet Oncology · 2013 · 733 citations · Full text
Serious Complications of Topical Mitomycin-C after Pterygium Surgery
Roy S. Rubinfeld, Roswell R. Pfister, Raymond Stein et al. · Ophthalmology · 1992 · 688 citations
Medicine, Ophthalmology, Surgery +17
Xiaojun Yang, Chaoqun Huang, Tao Suo et al. · Annals of Surgical Oncology · 2011 · 683 citations · Full text
1–5 of 3.5K
13.9K
21
h-index
20
h-index
15
h-index
14
h-index
13
h-index
1–5 of 13.9K
2.7K
Yale University
New Haven, United States
26 h-index
117 publications
7.8K citations
University College London
London, United Kingdom
24 h-index
95 publications
10.4K citations
University of Miami
Coral Gables, United States
24 h-index
105 publications
7.4K citations

Kyoto University
Kyoto, Japan
23 h-index
126 publications
4.9K citations

University of Toronto
Toronto, Canada
22 h-index
85 publications
4.6K citations
Harvard University
Cambridge, United States
22 h-index
70 publications
3.7K citations
Wayne State University
Detroit, United States
22 h-index
114 publications
8.1K citations

Wills Eye Hospital
Philadelphia, United States
21 h-index
62 publications
3.6K citations
1–8 of 2.7K
Repository · 436 publications · 17.1K citations
62
h-index
85 publications · 9.6K citations
57
h-index
123 publications · 8.3K citations
51
h-index
130 publications · 5.7K citations
43
h-index
BJO · 61 publications · 4.4K citations
42
h-index
1–5